# =============================================================================
# ESTADO DEL SISTEMA - Value Investor v4.0
# Actualizado 2026-02-07
# =============================================================================

system:
  system_version: "4.0.0"
  framework_version: "4.0"
  last_session: 2026-02-11
  session_number: 55

  # FRAMEWORK v4.0 - IMPLEMENTADO
  # =====================================
  framework_v4_status:
    status: IMPLEMENTED
    document: docs/evolution_framework_4.0.md
    implementation_date: 2026-02-05
    key_changes:
      - "Principios Adaptativos - razonamiento sobre reglas"
      - "NO hay parámetros fijos (7%, 25%, 35%)"
      - "learning/principles.md - 9 principios sin números (Principio 9 añadido Sesión 45)"
      - "learning/decisions_log.yaml - precedentes para consistencia"
      - "EXIT Protocol con 6 gates y Opportunity Score"
      - "consistency_checker.py - valida coherencia con precedentes"
      - "drift_detector.py - detecta cambios graduales"
      - "Investment Committee con 10 gates (Gate 10: Counter-Analysis)"
    files_created:
      - learning/principles.md
      - learning/decisions_log.yaml
      - .claude/skills/exit-protocol/SKILL.md
      - tools/consistency_checker.py
      - tools/drift_detector.py
    files_updated:
      - CLAUDE.md
      - .claude/skills/investment-rules/SKILL.md
      - tools/constraint_checker.py
    files_removed:
      - config/rules.yaml
      - config/memory_management.yaml
    consistency_fixes:
      - "SHEL → SHEL.L normalizado"
      - "LIGHT.NV → LIGHT.AS normalizado"

  # FRAMEWORK v3.0 - ARCHIVED (replaced by v4.0)
  # =============================================
  framework_v3_status:
    status: ARCHIVED
    replaced_by: "v4.0"
    original_document: docs/framework_v3.0_final_design.md

  # QUALITY SCORE - PORTFOLIO ANALYSIS (Updated 2026-02-11)
  # ===============================================
  portfolio_quality_analysis:
    date: 2026-02-11
    summary:
      total_positions: 13
      tier_a_count: 3  # MONY.L(81), LULU(82), ADBE(76 tool, 73 adj borderline)
      tier_b_count: 5  # AUTO.L(71 adj), NVO(73), BYIT.L(68-72), EDEN.PA(62), DOM.L(61). VICI REIT-adj ~60 borderline.
      tier_c_count: 5  # ALL(56), VICI(54), GL(52), UHS(51), DTE.DE(48)
      tier_d_count: 0
    positions:
      # TIER A - Quality Compounders (3 positions)
      - { ticker: MONY.L, score: 81, tier: A, status: "UK price comparison. Adversarial FV 201 GBp. HOLD LOW through Feb 23 earnings." }
      - { ticker: LULU, score: 82, tier: A, status: "Adversarial 2026-02-11: FV $261→$202 (-22.6%). QS 80-81 Tier A. HOLD LOW-MEDIUM." }
      - { ticker: ADBE, score: 76, tier: A, status: "QS Tool 76. Adj 73 (Tier B borderline) per FTC risk. Thesis v2.0 2026-02-10." }
      # TIER B - Quality Value (5 positions)
      - { ticker: NVO, score: 73, tier: B, status: "QS Tool 73 (Tier B). Thesis overclaimed 82 Tier A." }
      - { ticker: AUTO.L, score: 71, tier: B, status: "Adversarial 2026-02-11: QS 79→71 (Tier A→B). FV 688→617p (-10.3%). HOLD MEDIUM." }
      - { ticker: BYIT.L, score: 68, tier: B, status: "Adversarial 2026-02-11: QS 81→68-72 (Tier A→B). FV 455→345 GBp (-24.2%). HOLD PROBATION LOW." }
      - { ticker: EDEN.PA, score: 62, tier: B, status: "Adversarial FV EUR 29.0. HOLD MEDIUM through Feb 24 earnings." }
      - { ticker: DOM.L, score: 61, tier: B, status: "Adversarial FV 240 GBp. HOLD LOW through Mar 5 results." }
      # TIER C - Special Situations (5 positions)
      - { ticker: ALL, score: 56, tier: C, status: "ON PROBATION LOW. ROE 37% = peak cycle." }
      - { ticker: VICI, score: 54, tier: C, status: "REIT-Adj ~60 Tier B borderline. ON PROBATION through Feb 25 earnings." }
      - { ticker: GL, score: 52, tier: C, status: "Adj 55 Tier B borderline. SEC+DOJ cleared. FV $191." }
      - { ticker: UHS, score: 51, tier: C, status: "ON PROBATION. FV $213. Medicaid cuts = structural risk. Feb 25 earnings decisive." }
      - { ticker: DTE.DE, score: 48, tier: C, status: "FV EUR 35.00 (v3.1 post-TMUS beat). Feb 26 DTE earnings. MoS 14.4%." }
    diagnosis: |
      Session 54: 13 positions active. Adversarial review ALL 5 FASES COMPLETED.
      AUTO.L reclassified Tier A→B (QS 79→71). BYIT.L Tier A→B (QS 81→68-72).
      True Tier A count: 3 (MONY.L 81, LULU 82, ADBE 76/adj 73 borderline).
      Tier B count: 5 (NVO 73, AUTO.L 71, BYIT.L 68, EDEN.PA 62, DOM.L 61).
      Tier C count: 5 (ALL 56, VICI 54, GL 52, UHS 51, DTE.DE 48).
      8 positions sold + 3 standing orders cancelled through adversarial program.
      Cash EUR 4,844 (~44%) — quality deployment is PRIORITY.
      Pipeline: DSY.PA (standing order EUR 15.50 approved), PAYC (earnings today, entry $95-105), MORN ($145 watchlist, earnings Feb 12), DNLM.L (750-800p).
      Earnings week Feb 23-26: MONY.L, EDEN.PA, VICI (PROBATION), UHS (PROBATION), DTE.DE, WKL.AS. Frameworks ready for all 4 critical positions.

  # Archived session summaries (sessions 31-52) moved to state/session_summaries_archive.yaml
  # Purged 2026-02-11 to reduce file size (~730 lines removed)

  last_session_summary: |
    Session 55 - EARNINGS FRAMEWORKS + STANDING ORDER AUDIT (2026-02-11)

    =====================================================
    EARNINGS FRAMEWORKS CREATED
    =====================================================
    - VICI Q4 (Feb 25): PROBATION. AFFO guide <$2.35 = SELL. Rent cut >10% = SELL (KC#7).
      See thesis/active/VICI/earnings_framework_feb2026.md
    - UHS Q4 (Feb 25-26): PROBATION. EPS guide <$20 = SELL (KC#5). BH volumes decline = SELL.
      See thesis/active/UHS/earnings_framework_feb2026.md
    - MONY.L (Feb 23) and EDEN.PA (Feb 24): frameworks already existed, confirmed valid.

    =====================================================
    TIERING CORRECTED
    =====================================================
    - AUTO.L reclassified Tier A → Tier B (QS 79→71 post-adversarial)
    - Tier A: 3 (MONY.L 81, LULU 82, ADBE 76)
    - Tier B: 5 (NVO 73, AUTO.L 71, BYIT.L 68, EDEN.PA 62, DOM.L 61)
    - Tier C: 5 (ALL 56, VICI 54, GL 52, UHS 51, DTE.DE 48)

    =====================================================
    STANDING ORDERS RECALIBRATED
    =====================================================
    - MA BUY: $395→$315 (MoS 6%→25%). Post-adversarial MoS standard.
    - V BUY: $280→$220 (MoS 3%→24%).
    - V ADD: $265→$200 (MoS 8%→31%).
    - Pipeline warnings added to FGP.L, CMCSA, MA, V: "DO NOT EXECUTE without adversarial"

    PIPELINE AUDIT:
    - Adversarial complete (ready to execute): DSY.PA, DNLM.L
    - OK for ADD (active positions): GL, NVO
    - Need pipeline before execution: FGP.L, CMCSA, MA, V
    - Under review (Feb 19 Rose plan): WPP.L

    =====================================================
    WORK FOR NEXT SESSION
    =====================================================
    1. PAYC Q4 earnings (published Feb 11 after close) → verify with price_checker + web search
    2. MORN Q4 earnings (Feb 12 after close) → evaluate per framework
    3. WPP.L Rose plan Feb 19 → cancel/keep decision
    4. Earnings week Feb 23-26: all frameworks ready
    5. Cash deployment (~44%) — pipeline: PAYC, MORN, DSY.PA, DNLM.L

    Previous session (53-54): DSY.PA buy-pipeline completed, PAYC R1 thesis, full universe screening.
    - 5 fases: earnings_urgentes → tier_c → standing_orders → tier_b → tier_a
    - ~6 sesiones estimadas (49-55)
    - Pipeline position-review actualizado a v2.0 (adversarial permanente)

    =====================================================
    SYSTEM CHANGES
    =====================================================
    - state/system.yaml: adversarial_review tracker creado
    - pipelines/SKILL.md: position-review v2.0 (adversarial por defecto)
    - MEMORY.md: ACTIVE PROJECT section para persistencia
    - DNLM.L price monitor: 900p → 780p (midpoint 750-800)
    - 6 ficheros audit trail en thesis/research/DNLM.L/

    =====================================================
    PROXIMA SESION (49)
    =====================================================
    1. Adversarial review FASE 1: MONY.L + EDEN.PA (earnings Feb 23-24)
    2. Triage: forward_return.py + price_checker.py para priorizar
    3. Branch feature/refactor_claude_md: commit + merge aun pendiente
    4. DNLM.L interinos Feb 10: monitorear resultado
    5. CVS earnings Feb 11 (watchlist)

  status: active

# -----------------------------------------------------------------------------
# CALENDARIO
# -----------------------------------------------------------------------------
calendar:
  events:
    # WEEK OF FEB 3-7
    - date: 2026-02-03
      type: action_completed
      ticker: SHEL
      event: "DONE - TRIM SHEL: vender 10 acciones"
      priority: CRITICAL
      action: "SELL 10 shares SHEL en eToro. 20.85-10.85. Rebalanceo 13%-7%."

    - date: 2026-02-03
      type: action_completed
      ticker: A2A.MI
      event: "DONE - BUY A2A.MI ~134 shares"
      priority: CRITICAL
      action: "BUY ~134 shares A2A.MI ~2.54. Total ~340 (4%). Max entry 2.80."

    - date: 2026-02-03
      type: action_completed
      ticker: EDEN.PA
      event: "DONE - BUY EDEN.PA ~22 shares"
      priority: CRITICAL
      action: "BUY ~22 shares EDEN.PA ~17.67. Total ~400 (4%). FV 33-36."

    - date: 2026-02-03
      type: action_completed
      ticker: VNA.DE
      event: "DONE - BUY VNA.DE ~16 shares"
      priority: CRITICAL
      action: "BUY ~16 shares VNA.DE ~24.61. Total ~400 (4%). FV 35-38."

    - date: 2026-02-03
      type: earnings_completed
      ticker: PFE
      event: "DONE - Pfizer Q4 2025: BEAT EPS $0.66 vs $0.57, guidance reaffirmed"
      priority: high
      action: "HOLD - MoS 8.7%, dividend maintained. No action needed."

    - date: 2026-02-03
      type: action_completed
      ticker: TEP.PA
      event: "DONE - TRIM TEP.PA: sold 3 shares"
      priority: high
      action: "Sold 3 shares @ 53.14 = 159. Position 7.8%-6.1%. Constraint resolved."

    - date: 2026-02-03
      type: analysis_completed
      ticker: HPQ
      event: "HPQ RE-EVALUATED v2.0: REJECTED as value trap"
      priority: high
      action: "Standing order ELIMINATED. Thesis archived. 4/10 value trap factors, MoS 22% vs 35% required."

    - date: 2026-02-03
      type: analysis_completed
      ticker: UTG.L
      event: "UTG.L RE-EVALUATED v2.0: Standing order VALIDATED at 540 GBp"
      priority: high
      action: "FV updated 745p (was 770p). MoS at 540p = 27.5%. Tier B REIT. Value trap 1.5/10."

    - date: 2026-02-04
      type: action_completed
      ticker: FUTR.L
      event: "DONE - SOLD FUTR.L 111 shares (Tier D violation resolved)"
      priority: CRITICAL
      action: "SOLD 111 shares FUTR.L @ 522.50 GBp. P&L -2.8% (-€23). Cash +€672. Capital ready for quality compounders."

    - date: 2026-02-04
      type: action_completed
      ticker: ADBE
      event: "DONE - BUY ADBE 2 shares (First Tier A Quality Compounder!)"
      priority: high
      action: "BUY 2 shares ADBE @ $270.60. Total $541.20. QS 76, MoS 31%. At 52w low. FV $394."

    - date: 2026-02-05
      type: earnings
      ticker: GL
      event: "Globe Life Q4 2025 (after market close)"
      priority: high
      action: "Watch: EPS $3.44 consensus, FY2026 guidance. If beat - may re-rate. If miss - evaluate position. MoS at $143 = 17.6%."

    - date: 2026-02-05
      type: earnings
      ticker: ALL
      event: "Allstate Q4 2025"
      priority: high
      action: "Watch combined ratio Q4, guidance 2026 mid-90s, PIF growth."

    - date: 2026-02-05
      type: earnings
      ticker: SHEL.L
      event: "Shell Q4 2025"
      priority: high
      action: "Watch FCF, buyback $3.5B, guidance."

    - date: 2026-02-05
      type: action_completed
      ticker: NVO
      event: "DONE - BUY NVO 8.31 shares (Second Tier A Quality Compounder!)"
      priority: high
      action: "BUY 8.31 shares NVO @ $48.13. Total $400. QS 82 Tier A, MoS 38%. Framework v3.0 validated. Phased entry 4%."

    - date: 2026-02-05
      type: action_completed
      ticker: LULU
      event: "DONE - BUY LULU 2 shares (Fourth Tier A Quality Compounder!)"
      priority: high
      action: "BUY 2 shares LULU @ $171.62. Total $343.24. QS 82 Tier A, MoS 34%. Fallen angel -58%, problema ciclico no estructural."

    - date: 2026-02-05
      type: action
      ticker: EVO.ST
      event: "POST-EARNINGS: Evaluar compra Evolution AB"
      priority: high
      action: "Si buenos + UKGC OK - BUY hasta 650 SEK (~400). Si malos - 480-530 SEK. Si UKGC revocacion - DESCARTAR."

    - date: 2026-02-05
      type: standing_order_alert
      ticker: ZIG.L
      event: "ZIG.L -3.4% del trigger (388 GBp vs 375 GBp)"
      priority: high
      action: "MONITOR DIARIO. Si llega a 375 GBp - EJECUTAR standing order (350 EUR, 81 shares)."

    - date: 2026-02-05
      type: standing_order_alert
      ticker: EVO.ST
      event: "EVO.ST BAJO trigger (581 SEK < 600 SEK) pero CONDICIONADO"
      priority: high
      action: "ESPERAR earnings Feb 5. Si UKGC favorable + resultados OK - EJECUTAR. Si UKGC revocación - CANCELAR."

    - date: 2026-02-06
      type: action_completed
      ticker: SHEL.L
      event: "DONE - SOLD SHEL.L full exit 10.848578 shares @ 2774.50 GBp"
      priority: high
      action: "EXIT - QS 36, MoS -3.5%. Capital rotated to AUTO.L. P&L +2.3% (+8 EUR)."

    - date: 2026-02-06
      type: action_completed
      ticker: AUTO.L
      event: "DONE - BUY AUTO.L 65 shares @ 485.80 GBp (Fifth Tier A Quality Compounder!)"
      priority: high
      action: "BUY 65 shares AUTO.L @ 485.80 GBp. Total ~363 EUR. QS 79 Tier A, MoS 29%. UK car classifieds monopoly. ADD trigger 450p."

    - date: 2026-02-07
      type: action_completed
      ticker: TEP.PA
      event: "DONE - SOLD TEP.PA full exit 11.015 shares @ ~52.18 EUR"
      priority: high
      action: "EXIT - QS 46 Tier C, MoS 17%, ROIC < WACC, AI disruption. Capital rotated to BYIT.L. P&L -6.7% (-48 EUR)."

    - date: 2026-02-07
      type: action_completed
      ticker: LIGHT.AS
      event: "DONE - SOLD LIGHT.AS full exit 28.753 shares @ ~20.06 EUR"
      priority: high
      action: "EXIT - QS 56 Tier B probation, MoS 8.4%, ROIC < WACC. Capital rotated to BYIT.L. P&L +13.7% (+70 EUR)."

    - date: 2026-02-07
      type: action_completed
      ticker: PFE
      event: "DONE - SOLD PFE full exit 18.664 shares @ ~$27.22"
      priority: high
      action: "EXIT - QS 47 Tier C, MoS -3.2% overvalued, ROIC < WACC, patent cliff. Capital rotated to BYIT.L. P&L +1.8% (+8 EUR)."

    - date: 2026-02-07
      type: action_completed
      ticker: BYIT.L
      event: "DONE - BUY BYIT.L 110 shares @ ~296 GBp (Sixth Tier A Quality Compounder!)"
      priority: high
      action: "BUY 110 shares BYIT.L @ 296 GBp. Total $444 (~377 EUR). QS 81 Tier A, MoS 35%. UK #1 software VAR. ADD trigger 260p."

    # PAYC + MORN EARNINGS (ADDED 2026-02-11)
    - date: 2026-02-11
      type: earnings_pending
      ticker: PAYC
      event: "PAYC Q4 2025 Earnings (after close)"
      priority: high
      action: "Consensus EPS $2.44, Rev $542.7M. Entry $95-105 post-earnings. Ronda 1 complete. Rondas 2-4 PAUSED pending results."

    - date: 2026-02-12
      type: earnings_pending
      ticker: MORN
      event: "MORN Q4 2025 Earnings (after close, 4 PM ET)"
      priority: high
      action: "Consensus EPS $2.34, Rev $627-634M. QS 83 Tier A. Pipeline candidate #3. Bear <$2.20/<$615M, Base $2.30-2.45/$625-640M, Bull >$2.50/>$645M. Watch: PitchBook growth, FY2026 guidance, credit margins."

    - date: 2026-04-15
      type: watchlist_review
      ticker: DSY.PA
      event: "DSY.PA Q1 2026 Results — MANDATORY STANDING ORDER REVIEW"
      priority: high
      action: "If Q1 growth <3%: CANCEL standing order (EUR 15.50). If Q1 growth >4%: consider revising entry to EUR 16-16.50. Also check 0APT data breach status. Committee decision: thesis/research/DSY.PA/committee_decision.md"

    # EARNINGS WEEK FEB 23-26 (FRAMEWORKS PREPARED 2026-02-05)
    - date: 2026-02-23
      type: earnings
      ticker: MONY.L
      event: "MONY.L FY2025 Results"
      priority: high
      action: "FRAMEWORK READY. Consensus EBITDA £142.7m. Bull >£145m, Base £140-145m, Bear <£140m. Kill: ROIC<20%, revenue decline >5%, dividend cut. See thesis/active/MONY.L/earnings_framework_feb2026.md"

    - date: 2026-02-24
      type: earnings
      ticker: EDEN.PA
      event: "EDEN.PA FY2025 Results"
      priority: high
      action: "FRAMEWORK READY. Consensus NI €220m. 2026 = rebasing year (2-4%). Bull NI>€225m, Base €215-225m, Bear <€215m. Kill: ROIC<15%, revenue decline >5% 2Q, div cut >20%. See thesis/active/EDEN.PA/earnings_framework_feb2026.md"


    - date: 2026-02-25
      type: earnings
      ticker: VICI
      event: "VICI Q4 2025 / FY2025 earnings (after close)"
      priority: critical
      action: "FRAMEWORK READY. ON PROBATION. FV $29.00. AFFO guide <$2.35 = SELL. Caesars rent cut >10% w/o comp = SELL (KC#7). Div cut = SELL. Guide $2.45+ = HOLD/UPGRADE. See thesis/active/VICI/earnings_framework_feb2026.md"

    - date: 2026-02-25
      type: watchlist_review
      ticker: WKL.AS
      event: "WKL.AS FY2025 Results - MANDATORY REVIEW TRIGGER"
      priority: high
      action: "Committee decision 2026-02-11: WATCHLIST at EUR 50-55. Decision tree: 6%+ organic growth + healthy cloud → Entry EUR 50-55. 5-6% organic → Entry EUR 48-52. <5% organic → REASSESS, EUR 42-45 max. Cloud <5% → KILL. EUR 200M buyback ends Feb 23. See thesis/research/WKL.AS/committee_decision.md"
    - date: 2026-02-26
      type: earnings
      ticker: TEP.PA
      event: "TEP.PA FY2025 Results (POSITION SOLD 2026-02-06)"
      priority: low
      action: "NO LONGER HOLDING. Monitor for sector intel only."

    - date: 2026-02-10
      type: thesis_update
      ticker: ADBE
      event: "DONE - Thesis v2.0: FTC/DOJ ROSCA risk integrated"
      priority: high
      action: "FV $394→$390 (FTC-adjusted -1%). QS Tool 76→Adj 73. KC#6 added (FTC churn). Trial Oct 19, 2026. HOLD, no ADD until clarity."

    - date: 2026-02-10
      type: thesis_update
      ticker: GL
      event: "DONE - Thesis v3.0: SEC/DOJ clearance + Q4 2025 update"
      priority: high
      action: "FV $174→$191 (+9.8%). QS Tool 52→Adj 55 (Tier B borderline). Conviction medium-low→medium. Standing order ADD $125 updated. FY26 guide $14.95-$15.65."

    - date: 2026-02-10
      type: thesis_update
      ticker: VICI
      event: "DONE - Thesis v3.0: Risk-sentinel ORANGE resolved. Caesars Regional lease + LV tourism + analyst downgrades integrated."
      priority: high
      action: "FV $33.75→$29.00 (-14.1%). QS Tool 54, REIT-Adj ~60 (Tier B). KC#7 added (rent cut >10% w/o compensation). HOLD PROBATION through Feb 25 earnings. Post-earnings SELL/HOLD/UPGRADE framework defined."

    - date: 2026-02-10
      type: thesis_update
      ticker: DTE.DE
      event: "DONE - Thesis v3.0: Risk-sentinel YELLOW resolved. Pre-earnings framework for Feb 26. TMUS CMD today."
      priority: high
      action: "FV EUR 37.50→34.00 (-9.3%). QS Tool 48 Tier C (no adj). Net neutrality low risk. MoS 10.5%. HOLD MEDIUM through Feb 26 earnings. Check TMUS results today."

    - date: 2026-02-11
      type: earnings
      ticker: TMUS
      event: "DONE - T-Mobile US Q4 2025 + Capital Markets Day"
      priority: completed
      action: "TMUS beat: Revenue $24.3B (+11.3%), postpaid adds 7.8M (beat guide), 2026 EBITDA guide $37-37.5B (+10%). DTE.DE thesis upgraded to v3.1, FV EUR 34→35."

    - date: 2026-02-11
      type: thesis_update
      ticker: DTE.DE
      event: "DONE - Thesis v3.1: TMUS Q4 beat incorporated. FV EUR 34→35."
      priority: high
      action: "FV EUR 34.00→35.00 (+2.9%). TMUS 2026 EBITDA guide $37-37.5B upgrades DTE EBITDA to EUR 48.5B. MoS 14.4%. TRIM trigger EUR 33→34. ADD trigger EUR 27→28. HOLD MEDIUM through Feb 26 DTE earnings."

    - date: 2026-03-15
      type: catalyst
      ticker: NVO
      event: "CagriSema vs Zepbound head-to-head data (critical catalyst)"
      priority: CRITICAL
      action: "If positive: ADD 2% to NVO position. If inferior: evaluate kill conditions."

    - date: 2026-09-24
      type: legal
      ticker: ADBE
      event: "ADBE FTC: Last day for dispositive motions (may force settlement)"
      priority: high
      action: "Monitor if motions filed. If summary judgment attempted, evaluate impact. May trigger pre-trial settlement."

    - date: 2026-10-07
      type: legal
      ticker: ADBE
      event: "ADBE FTC: Final Pretrial Conference"
      priority: high
      action: "Last chance for settlement before trial. If no settlement announced, prepare for binary outcome Oct 19."

    - date: 2026-10-19
      type: legal
      ticker: ADBE
      event: "ADBE FTC: JURY TRIAL (San Jose, Courtroom 3, Judge Noel Wise)"
      priority: CRITICAL
      action: "DECISION POINT. If favorable settlement/verdict: consider ADD. If adverse (fine >$500M + mandatory one-click): evaluate KC#6 activation."

    - date: 2026-02-03
      type: action_completed
      ticker: TATE.L
      event: "DONE - BUY TATE.L 66 shares"
      priority: high
      action: "Bought 66 shares TATE.L, $339.73 invested. Starter position 2.7%."

    - date: 2026-02-02
      type: action_completed
      ticker: DOM.L
      event: "DONE - BUY DOM.L 175 shares"
      priority: high
      action: "Bought 175 shares DOM.L, $436.52 invested. Master franchisee, 54% UK market share."

    - date: 2026-02-24
      type: earnings
      ticker: UTG.L
      event: "Unite Group FY2025 Preliminary Results"
      priority: high
      action: "Watch: FY2026 guidance, occupancy FY2027 reservations, Empiric synergies. If occupancy >95% - may trigger early. If <93% - lower trigger to 500p."

    - date: 2026-03-05
      type: earnings
      ticker: DOM.L
      event: "Dominos Pizza Group FY25 results"
      priority: high
      action: "Review EBITDA guidance, FCF, dividend policy, CEO appointment timeline. Kill conditions: ND/EBITDA >3x, FCF <60M, share <45%."

    - date: 2026-02-02
      type: action_completed
      ticker: UHS
      event: "DONE - BUY UHS 2 shares"
      priority: high
      action: "Bought 2 shares UHS, $402.84 invested. Behavioral health leader, P/E 9.6x."

    - date: 2026-02-26
      type: earnings
      ticker: UHS
      event: "UHS Q4 2025 / FY2025 earnings (estimated Feb 25-26)"
      priority: critical
      action: "FRAMEWORK READY. ON PROBATION. FV $213, price $227 = OVERVALUED. FY26 guide <$20 = SELL (KC#5). BH volumes decline = SELL (KC#4). Guide $20-22 = HOLD LOW. Guide >$22 + volumes up = UPGRADE. See thesis/active/UHS/earnings_framework_feb2026.md"

    - date: 2026-02-04
      type: action_cancelled
      ticker: HRB
      event: "CANCELLED - HRB ADD order was ERROR (price $27.90 unrealistic)"
      priority: low
      action: "Original order deleted. ADD trigger per thesis is <$35. Current price $37.20 = no action. Monitor for dip."

    - date: 2026-02-07
      type: action_completed
      ticker: DTE.DE
      event: "TRIM DTE.DE ejecutado 2026-02-03: vendidas 14 shares, posicion reducida a 7%"

    - date: 2026-02-11
      type: earnings
      ticker: CVS
      event: "CVS Health Q4 2025"
      priority: high
      action: "BEAT (EPS >$6.70, margin >8%) - ready_to_buy 300. MISS - descartar."

    - date: 2026-02-19
      type: earnings
      ticker: AGN.NV
      event: "Aegon FY2025"
      priority: high
      action: "Watch OCG 1.2B, solvency >180%. Si precio cae 5.90 - BUY."

    - date: 2026-02-23
      type: strategy
      ticker: ENEL.MI
      event: "Enel Capital Markets Day"
      priority: high
      action: "Si FV sube 11-12 - entry 8.50."

    - date: 2026-02-26
      type: earnings
      ticker: DTE.DE
      event: "Deutsche Telekom FY2025"
      priority: high
      action: "FV EUR 35.00 (v3.1). TMUS Q4 beat. Watch: Consolidated EBITDA vs EUR 48.5B est, FCF vs EUR 20.1B guide, EPS vs EUR 2.50 guide 2026, TMUS merger benefit, buyback 2026 EUR 2B. Kill: div cut, EBITDA miss >10%, FCF <EUR 17B. Framework pending — lower urgency (not probation, MoS 15%)."

    - date: 2026-02-26
      type: earnings
      ticker: CS.PA
      event: "AXA FY2025 results"
      priority: high
      action: "Si precio cae a 34.50-35.50 post-earnings - BUY 5% (~500). Combined ratio <90% + guidance OK = compra."

    - date: 2026-02-27
      type: earnings
      ticker: PROX.BR
      event: "Proximus FY2025 + Strategic Plan"
      priority: high
      action: "Si capex decline confirmado + plan Global creible - BUY 3% (~300) a 7.50-7.70. Si decepcionante - AVOID hasta 5-6."

    - date: 2026-02-28
      type: earnings
      ticker: ENGI.PA
      event: "Engie FY2025"
      priority: high
      action: "Watch FCF yield >5%, payout <80%, Debt/EBITDA <4x."

    - date: 2026-03-01
      type: earnings
      ticker: NTGY.MC
      event: "Naturgy FY2025"
      priority: high
      action: "Watch dividend, FCF, Debt/EBITDA <4x."

    - date: 2026-03-19
      type: earnings
      ticker: ENEL.MI
      event: "Enel FY2025 results"
      priority: medium

    # ADVERSARIAL FV ACCURACY CHECK (Devil's Advocate Session 53)
    - date: 2026-05-11
      type: system_review
      ticker: PORTFOLIO
      event: "3-month adversarial FV accuracy check — compare sold positions prices vs adversarial FV"
      priority: medium
      action: "Run price_checker on A2A.MI, VNA.DE, TATE.L, SAN.PA, HRB, IMB.L. Update portfolio/history.yaml adversarial_fv_tracking."

    # ALL-TIER-A FEASIBILITY REVIEW (Devil's Advocate Session 53)
    - date: 2026-05-11
      type: system_review
      ticker: PORTFOLIO
      event: "3-month review: is all-Tier-A strategy feasible? If cash still >30%, evaluate barbell alternative."
      priority: high
      action: "If cash >30%, formally evaluate: (A) All Tier A, (B) Tier A+B barbell, (C) Diversified quality. Document in decisions_log."

    # LIGHT.AS POSITION SOLD 2026-02-06
    - date: 2026-06-23
      type: catalyst
      ticker: LIGHT.AS
      event: "Signify Capital Markets Day (POSITION SOLD 2026-02-06)"
      priority: low
      action: "NO LONGER HOLDING. Monitor for sector intel only."

# -----------------------------------------------------------------------------
# WATCHLIST
# -----------------------------------------------------------------------------
watchlist:
  # QUALITY COMPOUNDERS PIPELINE (Framework v3.0 - Tier A)
  quality_compounders:
    # NOVO-B.CO/NVO MOVED TO PORTFOLIO 2026-02-05
    # MA ANALYZED 2026-02-05 - WATCHLIST (overvalued)
    - ticker: MA
      quality_score: 86
      tier: A
      current_price_usd: 538
      fair_value_usd: 420
      entry_price_usd: 315
      mos_current: "-28% (OVERVALUED)"
      mos_required: "25%"
      status: "WATCHLIST - Wait for $315 (-41% from current). Recalibrated from $395."
      notes: "QS 86 confirmed. ROIC 44%, FCF 48%. Wide moat. P/E 33x needs correction to ~19x. Entry recalibrated 2026-02-11 per post-adversarial MoS standards."
    - ticker: V
      quality_score: 80
      tier: A
      current_price_usd: 329
      fair_value_usd: 275-290
      entry_price_usd: 220
      entry_price_add: 200
      mos_current: "-13 to -20% (OVERVALUED)"
      mos_required: "25%"
      status: "WATCHLIST - Wait for $220 (-33% from current). Recalibrated from $280."
      notes: "QS 80 confirmed. ROIC 50%+, FCF 54%, #1 share 52%. Entry recalibrated 2026-02-11: BUY $220 (24% MoS), ADD $200 (31% MoS). Post-adversarial MoS standards."
    - ticker: ADBE
      quality_score: 76
      tier: A
      current_price_usd: 272
      at_52w_low: true
      mos_required: "10-15%"
      status: "ANALYZE PRIORITY - At 52w low, AI beneficiary"
      notes: "P/E 16.3x ONLY! -51% from 52wH. Creative monopoly + AI. Low cap alloc score."
    - ticker: GOOGL
      quality_score: 76
      tier: A
      current_price_usd: 340
      mos_required: "10-15%"
      status: "ANALYZE - Near 52w high, wait for pullback"
      notes: "P/E 33.6x. Search + Cloud + YouTube moat."

  # QUALITY VALUE (Framework v3.0 - Tier B)
  quality_value:
    - ticker: META
      quality_score: 74
      tier: B
      current_price_usd: 692
      mos_required: "20-25%"
      notes: "P/E 29.4x. -27% from 52wH. Social moat + AI."
    - ticker: ASML
      quality_score: 66
      tier: B
      mos_required: "20-25%"
      notes: "Lithography monopoly. Wait for analysis."

  ready_to_buy:
    - ticker: TTE
      target_entry_eur: 45
      fair_value_eur: 60-83
      margin_of_safety: 26%
      sizing: "1,170 (7%)"
      status: "WAIT - current ~61 = 0% MoS. Need earnings + correction."
      thesis: thesis/watchlist/TTE/thesis.md

    - ticker: LGEN.L
      target_entry_gbp: 215
      sizing: "1,170 (7%)"
      status: "ON WATCH - wait FY2025 results"
      notes: "P/E ~10x, yield 8.5%, BofA 17.5% capital return"

    - ticker: EVO.ST
      target_entry_sek: 480-650
      fair_value_sek: 1009
      margin_of_safety: 42.6%
      sizing: "400 (4%)"
      status: "WAIT earnings 5-feb"
      thesis: thesis/research/EVO.ST/thesis.md


  tier_2:
    - ticker: AGN.NV
      entry: "5.90-6.10"
      notes: "P/E 7.4x, yield 5.8%. Borderline MoS. Earnings 19-Feb."
    - ticker: MBG.DE
      entry: "48-52"
      notes: "Current 57. Need 30%+ MoS. Q4 earnings catalyst."
    - ticker: CS.PA
      entry: "34.50-35.50"
      notes: "AXA. Tier A (8/10). FV 40.50. Wide moat. Solvency 222%. WAIT FY2025 earnings 26-feb."
    - ticker: ORA.PA
      entry: "13-14"
      notes: "Orange. Current 15.62 above old target. P/E 41x = expensive. Needs re-evaluation or REMOVE."
    - ticker: RIO.L
      entry: "120"
      notes: "Materials diversification. Lithium pivot."
    - ticker: ENGI.PA
      entry: "22"
      notes: "Yield 6.6%. Needs fundamental analysis."
    - ticker: NTGY.MC
      entry: "19-21"
      notes: "Yield conflict. Needs data validation."
    - ticker: CMCSA
      entry: "$25-26"
      notes: "FV $33-38 (adjusted for normalized FCF + $90B debt). Broadband moat ERODING (FWA, fiber). Peacock -$500M/Q. Theme parks bright spot. NO BUY at $29.75."
    - ticker: GIS
      entry: "$34-38"
      notes: "DCF ~$41. D/E 147%, GLP-1 headwind."
    - ticker: AZM.MI
      entry: "32-33"
      notes: "Asset manager. P/E 9.8x, yield 4.9%, D/E 0.01. Narrow moat. FV 42-44. Strong buy 30."
    - ticker: PROX.BR
      entry: "7.50-7.70"
      notes: "Telecom belga. EV/EBITDA 3.1x. FV 12 base. WAIT strategic plan 27-feb. DIGI risk."

  on_watch:
    - ticker: ENEL.MI
      entry: "7.00-7.50"
      notes: "Vendida breakeven. CMD 23-feb catalyst."
    - ticker: CVS
      entry: "$70"
      notes: "Turnaround. Q4 11-feb binary event."
    - ticker: AMT
      entry: "$160-165"
      notes: "Infrastructure REIT. Debt/EBITDA 6.18x."
    - ticker: IBE.MC
      entry: "14-15"
      notes: "Quality but P/E 21-24x premium."
    - ticker: ADM.L
      entry: "24-26"
      notes: "ROE 56% but margin -16%."
    - ticker: 8001.T
      entry: "6,500 ($43)"
      notes: "Itochu. Quality premium in price."
    # TATE.L REMOVED 2026-02-08 - Position closed (adversarial review, QS 45 Tier C, FV -40%)
    - ticker: BME.L
      entry: "169 GBp"
      notes: "B&M discount retail. FV 260p. At 169p = 35% MoS Tier C. Or wait H2 June 2026. D/E high (IFRS16). Narrow moat."
    - ticker: TBCG.L
      entry: "3500 GBp"
      notes: "TBC Bank Georgia. ROE 24%, P/E 6.6x. MoS 21% at 4265 = FAIL Tier C. At 3500 = 35% MoS. Max 4%. Frontier risk."
    - ticker: BGEO.L
      entry: "7000 GBp"
      notes: "Lion Finance (ex-Bank of Georgia). P/E 7.9x, ROE 29%. Near 52w high (9975 vs 10230). NO discount. Wait -30% correction. Same Georgia risk as TBCG."
    - ticker: WPP.L
      entry: "200 GBp"
      notes: "v2.0: Probable value trap (5-6/10). FV 380p. MoS 28% vs 35% required. Standing order 200p = 47% MoS. Wait Rose plan Feb 19."
    - ticker: UTG.L
      entry: "540 GBp"
      fair_value: "745 GBp"
      fair_value_v2: "745p (central), Bear 610p, Bull 870p"
      notes: "v2.0 RE-EVAL: MoS at 540p = 27.5% (PASSES 25% Tier B). FY2026 earnings trough -7-10%. 42% discount to NAV 986p. Near-monopoly UK listed PBSA. Value trap 1.5/10. Earnings Feb 24."
      kill: "Occupancy <90%, dividend cut, LTV >35%, immigration policy kills int'l student demand"
    - ticker: MEGP.L
      entry: "131 GBp"
      fair_value: "175 GBp"
      notes: "ME Group. ROE 31.8%, EBITDA margin 37%, net cash, monopoly laundry kiosks. Only 2 analysts. At 131p = 25% MoS. FY2025 results mid-Feb catalyst."
      kill: "German photo regulation kills Photo.ME division, laundry growth stalls <10%"

  archived_rejected:
    - ticker: HPQ
      rejection_date: 2026-02-03
      reason: "VALUE TRAP - 4/10 trap factors (secular printing decline, digital disruption, negative equity, heavy insider selling). MoS 22% vs 35% required for Tier C. CEO departed. No moat. Thesis archived."
      fair_value: "$21-24"
      entry_would_need: "$15.35 (for 35% MoS)"
      thesis: thesis/archive/HPQ/thesis.md

    - ticker: MEGP.L
      rejection_date: 2026-02-03
      reason: "NOT AVAILABLE ON ETORO - Excellent company (ROE 31.8%, MoS 29%, value trap 0.5/10) but broker doesn't offer this LSE micro-cap. Consider if switching brokers."
      fair_value: "195 GBp"
      thesis: thesis/archive/MEGP.L/thesis.md

    - ticker: CAG
      rejection_date: 2026-02-04
      reason: "VALUE TRAP 5/10 - Q2 FY26 loss $664M, impairment $968M, ROIC 5.3% barely covers WACC, dividend payout -667% (paying from losses). Worst margins in sector. GIS is better choice if want food exposure."
      fair_value: "$17.50 (current $19.11 = overvalued)"
      thesis: thesis/research/CAG/thesis.md

  active_monitoring:
    - ticker: A2A.MI
      entry: 2.548
      fair_value: 3.62
      kill: "FCF decline >15% or dividend cut"
    - ticker: EDEN.PA
      entry: 17.61
      fair_value: 38.4  # EUR, probability-weighted (thesis v3.0)
      kill: "FCF <300M or revenue decline >10%"
    - ticker: VNA.DE
      entry: 24.55
      fair_value: 35-38
      kill: "FFO/share decline >15% or dividend cut"
    - ticker: DTE.DE
      entry: 31.85
      fair_value: 58-74
      kill: "T-Mobile US spin-off fails or EBITDA decline >10%"
    # SHEL.L REMOVED 2026-02-06 - Position closed, capital rotated to AUTO.L
    - ticker: AUTO.L
      entry_gbp: 485.80
      fair_value_gbp: 688
      mos: 29%
      tier: A
      quality_score: 79
      notes: "Fifth Tier A Quality Compounder. UK car classifieds monopoly. 75% market share, 50% FCF margin, net cash. ADD trigger at 450p (MoS >34%)."
      kill: "Dealer count decline >5%, ARPR growth negative, competitor >20% share, FCF margin <35%, large M&A >GBP 1B"
    # PFE REMOVED 2026-02-06 - Position closed, capital rotated to BYIT.L
    - ticker: ALL
      entry_usd: 196.00
      fair_value_usd: 240-260
      kill: "Combined ratio >100% sustained or catastrophe losses >$5B"
    # TEP.PA REMOVED 2026-02-06 - Position closed, capital rotated to BYIT.L
    # SAN.PA REMOVED 2026-02-09 - Position closed (adversarial review, ROIC<WACC, FV -35.5%, P&L -0.84%)
    - ticker: VICI
      entry_usd: 28.57
      fair_value_usd: 29.00
      kill: "Dividend cut, tenant bankruptcy, rent cut >10% w/o compensation (KC#7), AFFO guidance <$2.35, credit rating <BB+"
      status: "ON PROBATION. HOLD through Feb 25 earnings. Post-earnings SELL/HOLD/UPGRADE decision."
    # IMB.L REMOVED 2026-02-10 - Position closed (+6.9%), adversarial review QS 54 Tier C, MoS -14.6%
    # LIGHT.AS REMOVED 2026-02-06 - Position closed (+13.7%), capital rotated to BYIT.L
    # TATE.L REMOVED 2026-02-08 - Position closed (adversarial review, QS 45, FV -40%)
    - ticker: DOM.L
      entry: 183
      fair_value: 240  # v3.0. Was 294p v2.0 (-18.4%)
      kill: "EBITDA <£125M (KC#1), Net Debt/EBITDA >3x, FCF <£40M 2yr, market share <48%, dividend cut, DPZ royalty >5%"
    - ticker: UHS
      entry_usd: 201.42
      fair_value_usd: 270-313
      kill: "ROIC < WACC 2 consecutive quarters, behavioral health volumes decline YoY, Medicaid cuts >$100M"
    - ticker: GL
      entry_usd: 141.06
      fair_value_usd: 174
      fair_value_original: 215
      fair_value_v2: 174
      mos_v2: 17.6%
      notes: "Framework v2.0 re-eval: P/B vs ROE + P/E normalized. 0/10 value trap. Beta 0.46. Quality 7/10 Tier B. MoS below 25% threshold - HOLD, no ADD."
      kill: "Operating EPS <$12, or class action reveals material new fraud evidence"
      buy_trigger: "$130 or below (MoS would be 25.3%)"
    # FUTR.L REMOVED 2026-02-04 - Position closed (Tier D violation)
    - ticker: NVO
      entry_usd: 48.13
      fair_value_dkk: 491
      fair_value_usd: 66  # approx, DKK 491 / 7.45
      mos: 38%
      tier: A
      quality_score: 82
      notes: "Framework v3.0 validated. Phased entry 4%. ADD trigger: CagriSema positive (Mar 2026) or price <$40."
      kill: "CagriSema inferior to Zepbound, market share <40%, gross margin <70%, dividend cut"
    - ticker: LULU
      entry_usd: 171.62
      fair_value_usd: 261
      mos: 34%
      tier: A
      quality_score: 82
      notes: "Fourth Tier A Quality Compounder. Fallen angel -58%. Problema ciclico (producto stale, US debil), NO estructural. ADD triggers: $160 (4.5%), $145 (5.5%)."
      kill: "Gross Margin <50%, 3Q consecutive negative global comps, FCF negative 2Q, bad CEO hire, Chip Wilson board takeover"
    - ticker: BYIT.L
      entry_gbp: 296
      fair_value_gbp: 455
      mos: 35%
      tier: A
      quality_score: 81
      notes: "Sixth Tier A Quality Compounder. UK #1 software VAR. Net cash, 30% FCF margin, 9.6% insider. Fallen angel -47% Microsoft incentive restructuring. ADD trigger 260p."
      kill: "Microsoft structurally disintermediates VARs, FCF negative 2+ years, services growth <10%, major customer/framework loss, QS <75"

# -----------------------------------------------------------------------------
# ALERTAS DE PRECIO
# -----------------------------------------------------------------------------
alerts:
  price_monitors:
    - { ticker: TTE, entry_eur: 45, note: "FV 60. Wait earnings+correction" }
    - { ticker: LGEN.L, entry_gbp: 215, note: "FV ~265p. Wait FY2025" }
    - { ticker: MBG.DE, entry_eur: 50, note: "FV 70. Cyclical wait" }
    - { ticker: ENEL.MI, entry_eur: 7.50, note: "Re-entry. CMD 23-feb" }
    - { ticker: AGN.NV, entry_eur: 5.90, note: "Borderline. Earnings 19-Feb" }
    - { ticker: CVS, entry_usd: 70, note: "Q4 11-feb binary" }
    - { ticker: T, entry_usd: 22.50, note: "FCF $18B+. Best US telecom" }
    - { ticker: BNP.PA, entry_eur: 78, note: "FV 103. CET1 12.5%" }
    - { ticker: ENGI.PA, entry_eur: 22, note: "FV 29. Yield 6%" }
    - { ticker: CS.PA, entry_eur: 35.50, note: "AXA. FV 40.50. Tier A. Earnings 26-feb" }
    # BME.L REMOVED 2026-02-09 - Standing order cancelled. Governance broken + ROIC collapsed.
    - { ticker: TBCG.L, entry_gbp: 3500, note: "TBC Bank Georgia. FV 5400p. Frontier Tier C." }
    - { ticker: BGEO.L, entry_gbp: 7000, note: "Lion Finance (ex-BOG). Near ATH, wait correction." }
    - { ticker: WPP.L, entry_gbp: 200, note: "v2.0: 5-6/10 trap. FV 380p. 47% MoS at trigger. Feb 19 Rose plan critical." }
    # TATE.L REMOVED 2026-02-08 - Position closed (adversarial review)
    - { ticker: DGE.L, entry_gbp: 1300, note: "Diageo v2.0: FV 1400-1520 GBp. OVERVALUED at 1690. Entry 1300 for 15% MoS." }
    - { ticker: EVO.ST, entry_sek: 530, note: "Evolution. Q4 MISS confirmed. FV revised 800-850 SEK. UKGC still pending. Entry 530 SEK ONLY if UKGC favorable." }
    - { ticker: GL, entry_usd: 130, note: "Globe Life ADD trigger. At $130 MoS=25.3%. Do not add >$130." }
    # UTG.L REMOVED 2026-02-09 - Standing order cancelled. QS Tier D + FV -17.4% adversarial.
    - { ticker: SRE.L, entry_gbp: 75, note: "Sirius RE. FV 100p. Entry 75p = 25% MoS. Refinancing Jun-2026 catalyst." }
    - { ticker: GIS, entry_usd: 38, note: "General Mills. FV $45-50. Entry $35-38. Quality 6.5/10 Tier B. GLP-1 headwind." }
    - { ticker: BATS.L, entry_gbp: 4200, note: "BAT. FV 5163p. Entry 4000-4200p. IMB.L sold 2026-02-10. Earnings 12-feb." }
    - { ticker: V, entry_usd: 220, note: "Visa. QS 80 Tier A. FV $275-290. Entry $220 (recalibrated from $280), ADD $200. Duopoly #1." }
    - { ticker: INGR, entry_usd: 105, note: "Ingredion. QS 57 Tier B. FV $167. Food ingredients. Wait Q1 earnings April 2026." }
    - { ticker: DBX, entry_usd: 20, note: "Dropbox. QS 73 Tier B but 5/10 value trap. FV $33. LOW PRIORITY. Declining users." }
    - { ticker: GSK.L, entry_gbp: 1850, note: "GlaxoSmithKline. QS 59 Tier B. FV 2424p. Entry 1850p = 24% MoS. Patent cliff 2027-28." }
    - { ticker: LULU, add_trigger_usd: 155, note: "POSITION ACTIVE (2 shares @ $171.62). ADVERSARIAL: ADD trigger $155 conditional on Q4 + CEO clarity. QS 80-81 Tier A. FV $202 (was $261)." }
    - { ticker: AUTO.L, add_trigger_gbp: null, note: "POSITION ACTIVE (65 shares @ 485.80p). ADVERSARIAL: ADD trigger CANCELLED. QS 63→71 (Tier B). FV 617p (was 688p). Wait FY2026 results May 2026." }
    - { ticker: BYIT.L, add_trigger_gbp: 240, note: "POSITION ACTIVE (110 shares @ 296p). ADVERSARIAL: ADD trigger 240p = MoS ~30% vs adversarial FV 345 GBp. QS 68-72 Tier B. HOLD PROBATION LOW. EXIT if FY2026 OP < GBP 66M." }
    - { ticker: DNLM.L, entry_gbp: 780, note: "Dunelm. QS 79 Tier A. FV 1008p (risk-adjusted, was 1328p). Entry 750-800p = MoS 21-26%. Adversarial pipeline: STRONG COUNTER on price, quality genuine. Wait post-interims Feb 10. Alt path: 850-900p if interims de-risk. Adderley sold 5% at 1140p Jul-2025." }
    - { ticker: WKL.AS, entry_eur: 55, note: "REVISED 2026-02-11. Committee FV EUR 72 (was 94.28). Entry EUR 50-55 post FY2025 results Feb 25. MoS 31-44% at target. HARD GATE: create sector view first. See committee_decision.md." }
    - { ticker: WKL.AS, entry_eur: 50, note: "STRONG ENTRY. Committee FV EUR 72. At EUR 50 = MoS 44%. Only if FY2025 shows 5%+ organic growth + healthy cloud metrics." }
    - { ticker: DSY.PA, entry_eur: 15.50, note: "Dassault Systemes. Committee APPROVED 2026-02-11. FV EUR 20.00. QS 70 Tier B. WIDE moat. HIGH risk. Standing order EUR 15.50 = MoS 22.5%. CONDITIONAL on Q1 2026 results. Cancel if growth <3%. 0APT data breach monitoring." }
    - { ticker: PAYC, entry_usd: 100, note: "Paycom. QS 85 Tier A. Ronda 1 complete. WATCHLIST. Earnings Feb 11 after close. Entry $95-105 post-earnings. Buy-pipeline Rondas 2-4 pending post-earnings." }
    - { ticker: MORN, entry_usd: 145, note: "Morningstar. QS 83 Tier A. Earnings Feb 12. Pipeline candidate #3. ROIC 20.5%, 45% insider. -53% from highs. Preliminary — buy-pipeline not started." }

# -----------------------------------------------------------------------------
# STANDING ORDERS (pre-aprobadas, ejecutar cuando precio toque trigger)
# El humano puede ejecutar en eToro sin esperar sesion.
# En siguiente sesion confirma y se actualiza portfolio.
# -----------------------------------------------------------------------------
standing_orders:
  # THESIS COMPLETA + COMMITTEE APROBADO - Solo falta que precio llegue
  # BME.L CANCELLED 2026-02-09 - Governance broken + ROIC collapsed. Adversarial review disqualified.
  # Was: BUY <=169 GBp, FV 321 GBp, MoS 47%. Cancelled per user instruction.

  # MEGP.L REMOVED 2026-02-03 - NOT AVAILABLE ON ETORO
  # Was: trigger 145 GBp, FV 195 GBp, MoS 29%. Excellent company but broker doesn't offer it.
  # See thesis/archive/MEGP.L/

  # UTG.L CANCELLED 2026-02-09 - QS Tier D + FV -17.4% in adversarial. Quality insufficient.
  # Was: BUY <=540 GBp, FV 745 GBp, MoS 27.5%. Cancelled per user instruction.

  # TATE.L REMOVED 2026-02-08 - Position closed (adversarial review, QS 45, FV -40%)

  # ZIG.L CANCELLED 2026-02-11 - Adversarial review: QS 34 tool (40 adj) = Tier C (was claimed Tier B).
  # FV 652→493 GBp (-24%). MoS at 375p only 24% (need 30%+ for Tier C).
  # Principio 9: 44% cash better deployed to Tier A, not Tier C cyclical with structural FCF weakness.
  # Was: BUY <=375 GBp, FV 652 GBp, MoS 42%. Cancelled per adversarial review verdict.

  # GL ADD - CONDITIONAL on price pullback (UPDATED v3.0 2026-02-10)
  - ticker: GL
    action: ADD
    trigger: "<=$125"
    size_eur: 300
    shares_approx: 2
    thesis: thesis/active/GL/thesis.md
    fair_value: "$191"
    mos_at_trigger: "34.5%"
    notes: "Globe Life v3.0. SEC+DOJ cleared Jul 2025. FV $191 (was $174). At $125 = 34.5% MoS. Near management buyback avg $126. QS Adj 55 Tier B borderline."
    expiry: 2026-08-01

  # HRB ADD - EXECUTED 2026-02-05
  # - ticker: HRB
  #   action: ADD
  #   trigger: "<=$35"
  #   EXECUTED: 2026-02-05, 10 shares @ $34.50, total $345

  # EVO.ST CANCELLED 2026-02-11 - Tier C + regulatory risk + Q4 miss. Principio 9: capital for Tier A.
  # Was: BUY <=530 SEK, FV 800-850 SEK. Cancelled per Devil's Advocate systemic review.

  # FGP.L - KEPT. Tier B, narrow moat but UK bus/rail monopoly characteristics.
  # Under review — may cancel if quality screening produces better Tier A/B candidates.
  - ticker: FGP.L
    action: BUY
    trigger: "<=165 GBp"
    size_eur: 400
    shares_approx: 209
    thesis: thesis/research/FGP.L/thesis.md
    fair_value: "220-240 GBp"
    mos_at_trigger: "25%"
    notes: "FirstGroup. v2.0 CONFIRMED. UK bus/rail. P/E 9x, Tier B. Narrow moat. IFRS16 distorts FCF. FV blended 220-230p (EV/EBIT + P/E). Value trap 2/10. NOTE: adds UK concentration. WARNING: No adversarial buy-pipeline completed — DO NOT execute without full 4-round pipeline if price approaches trigger."
    expiry: 2026-06-01

  # BBWI CANCELLED 2026-02-11 - Tier C turnaround + $5B debt + negative equity. Principio 9.
  # Was: BUY <=$18.50, FV $29, MoS 36%. Cancelled per Devil's Advocate systemic review.

  - ticker: CMCSA
    action: BUY
    trigger: "<=$26"
    size_eur: 450
    shares_approx: 15
    thesis: thesis/research/CMCSA/thesis.md
    fair_value: "$33-38"
    mos_at_trigger: "26-31%"
    notes: "Comcast. Tier B. Broadband declining, theme parks star. $95B net debt. P/E 5.5x misleading (fwd 7.5x). Watch broadband losses. WARNING: No adversarial buy-pipeline completed — DO NOT execute without full 4-round pipeline if price approaches trigger."
    expiry: 2026-06-01

  - ticker: WPP.L
    action: BUY
    trigger: "<=200 GBp"
    size_eur: 400
    shares_approx: 173
    thesis: thesis/research/WPP.L/thesis.md
    fair_value: "380 GBp"
    mos_at_trigger: "47%"
    notes: "WPP turnaround. Tier C. No moat, AI disruption. Altman Z 1.06. Wait for Rose plan Feb 19."
    expiry: 2026-04-01
    status: "UNDER REVIEW — Tier C + no moat + AI disruption. Principio 9 says cancel. BUT Rose plan Feb 19 could be transformative. Decision: KEEP until Feb 19, evaluate Rose plan, then cancel if no upgrade path to Tier B."

  # NVO ADD - CONDITIONAL on CagriSema data or price drop
  - ticker: NVO
    action: ADD
    trigger: "CagriSema vs Zepbound POSITIVE (March 2026) OR price <=$40"
    size_eur: 300
    shares_approx: 6
    thesis: thesis/active/NVO/thesis.md
    fair_value: "$66 (DKK 491)"
    mos_at_trigger: "40%+ at $40"
    notes: "ADD to existing 8.31 shares. Brings position from 4% to 6-7%. Framework v3.0 Tier A."
    expiry: 2026-06-01

  # MA - Quality Compounder waiting for entry (RECALIBRATED 2026-02-11)
  - ticker: MA
    action: BUY
    trigger: "<=$315"
    size_eur: 500
    shares_approx: 1.6
    thesis: thesis/research/MA/thesis.md
    fair_value: "$420"
    mos_at_trigger: "25% at $315"
    tier: "A (QS 86)"
    notes: "Quality Compounder (ROIC 44%, FCF 48%). Currently $538 = far from trigger. Recalibrated from $395 (6% MoS) to $315 (25% MoS) per post-adversarial MoS standards. P/E at $315 ~19x. WARNING: No adversarial buy-pipeline completed — DO NOT execute without full 4-round pipeline if price approaches trigger."
    expiry: 2026-08-01

  # V - Quality Compounder waiting for entry (RECALIBRATED 2026-02-11)
  - ticker: V
    action: BUY
    trigger: "<=$220"
    size_eur: 500
    shares_approx: 2.3
    thesis: thesis/research/V/thesis.md
    fair_value: "$275-290"
    mos_at_trigger: "24% at $220 (vs FV $290 midpoint)"
    tier: "A (QS 80)"
    notes: "Quality Compounder (ROIC 50%+, FCF 54%, #1 market share 52%). Currently $329 = far from trigger. Recalibrated from $280 (3-5% MoS) to $220 (24% MoS) per post-adversarial standards. WARNING: No adversarial buy-pipeline completed — DO NOT execute without full 4-round pipeline if price approaches trigger."
    expiry: 2026-08-01

  - ticker: V
    action: ADD
    trigger: "<=$200"
    size_eur: 300
    shares_approx: 1.5
    thesis: thesis/research/V/thesis.md
    fair_value: "$275-290"
    mos_at_trigger: "31% at $200 (vs FV $290 midpoint)"
    tier: "A (QS 80)"
    notes: "ADD to existing position. Recalibrated from $265 (8-10% MoS) to $200 (31% MoS). Total target 5-6%. WARNING: No adversarial buy-pipeline completed — DO NOT execute without full 4-round pipeline if price approaches trigger."
    expiry: 2026-08-01

  # DSY.PA - Wide-moat mature software, Tier B entry (COMMITTEE APPROVED 2026-02-11)
  - ticker: DSY.PA
    action: BUY
    trigger: "<=EUR 15.50"
    size_eur: 330
    shares_approx: 21
    thesis: thesis/research/DSY.PA/thesis.md
    fair_value: "EUR 20.00 (valuation-specialist, committee-adopted)"
    mos_at_trigger: "22.5%"
    tier: "B (QS Tool 70, user override from adjusted 78)"
    notes: "Dassault Systemes. #1 PLM globally. WIDE moat (22/25). HIGH risk (7 HIGH/CRITICAL). Revenue CAGR 3.2%, flat EPS FY2026. Adobe parallel stripped per devil's advocate. Wait Q1 2026 results. CANCEL if Q1 growth <3% or data breach escalation."
    expiry: 2026-05-15
    conditions:
      - "Wait for Q1 2026 results (April-May) before executing"
      - "Cancel if Q1 revenue growth <3%"
      - "Cancel if 0APT data breach escalates to defense customer loss"
      - "Review in 30 days regardless"

  # DNLM.L - Tier A fallen angel, entry on pullback (ADVERSARIAL REVISED 2026-02-09)
  - ticker: DNLM.L
    action: BUY
    trigger: "<=780 GBp"
    size_eur: 375
    shares_approx: 42
    thesis: thesis/research/DNLM.L/thesis.md
    fair_value: "1008 GBp (adversarial, was 1328)"
    mos_at_trigger: "23% at 780p"
    tier: "A (QS 79)"
    notes: "UK #1 homewares. 38.5% insider (Adderley family). ADVERSARIAL FV 1,008p (-24% vs thesis). 5 material risks found. Devil's advocate STRONG COUNTER 9/19. Committee: WATCHLIST at 750-800p."
    kill_conditions: "Insider ownership <25%, FCF negative 2+ years, gross margin <45%, store closures >10%"
    expiry: 2026-06-01

  # WKL.AS CANCELLED 2026-02-11 - Investment Committee Ronda 4: WATCHLIST verdict.
  # FV revised EUR 94.28→72 (-24%). MoS at EUR 65 only 9.6% (insufficient for Tier B + STRONG COUNTER).
  # 3 gates FAILED (no sector view, MoS insufficient, no sector understanding).
  # New entry target: EUR 50-55 post FY2025 results (Feb 25).
  # See thesis/research/WKL.AS/committee_decision.md for full 10-gate review.
  #   # WKL.AS - Tier B, AI disruption overpriced
  #   - ticker: WKL.AS
  #     action: BUY
  #     trigger: "<=65 EUR"
  #     size_eur: 325
  #     shares_approx: 5
  #     thesis: thesis/research/WKL.AS/thesis.md
  #     fair_value: "94.28 EUR"
  #     mos_at_trigger: "31%"
  #     tier: "B (QS 72)"
  #     notes: "Market conflates 'information' with 'workflow'. Only 8-10% revenue at AI risk. Wait full-year results late Feb."
  #     kill_conditions: "Revenue decline >5% 2Q, customer churn >10%, AI competitor >15% share"
  #     expiry: 2026-06-01

  # BYIT.L ADD - REVISED 2026-02-11 (adversarial: FV 455→345, QS 81→68-72 Tier B)
  - ticker: BYIT.L
    action: ADD
    trigger: "<=240 GBp"
    size_eur: 200
    shares_approx: 83
    thesis: thesis/active/BYIT.L/thesis.md
    fair_value: "345 GBp (adversarial)"
    mos_at_trigger: "30%"
    tier: "B (QS 68-72)"
    notes: "REVISED adversarial. ADD only after H2 FY2026 OP confirms recovery (>GBP 66M). If OP declines, EXIT instead."
    expiry: 2026-06-01

# -----------------------------------------------------------------------------
# MACRO (resumen)
# -----------------------------------------------------------------------------
macro_snapshot:
  last_update: 2026-02-02
  themes: ["Fed/BCE pausa 3.5%/2.0%", "Europa barata", "Tariffs escalando (Corea 25%, Canada amenaza)", "Iran tension up", "China mejora IMF 4.5%", "Alemania sale recesion"]
  risks: ["US-Iran guerra regional 30-40% (up)", "US-China Taiwan 10-20%", "Tariff war global 40-50%", "Recesion US 25-35%", "Oil shock >$90 si Iran 15-25%"]

# -----------------------------------------------------------------------------
# MANTENIMIENTO
# -----------------------------------------------------------------------------
maintenance:
  last_health_check: 2026-02-04
  next_health_check_due: 2026-02-18
  health_score: 9.1/10
  health_check_issues:
    - severity: WARNING
      issue: "Falta sector view energy.md - SHEL.L es posicion activa sin cobertura"
      action: "Crear world/sectors/energy.md"
    - severity: WARNING
      issue: "CLAUDE.md 752 lineas (>150 limite)"
      action: "Considerar compactacion/extraction a skills si sigue creciendo"
    - severity: INFO
      issue: "LIGHT.NV vs LIGHT.AS ticker inconsistencia en transacciones"
      action: "Normalizar a LIGHT.AS"
  last_compact: 2026-02-01
  memory_status: ok
  agents_count: 24  # Added devil's-advocate for adversarial counter-analysis
  skills_count: 21  # Added: news-classification, error-detector, recommendation-context
  tools_count: 7
  rules_count: 6   # Added: meta-reflection-integration
  evolution_tracking:
    last_evaluation: 2026-02-05
    applied_2026_02_05_session38_v4_compliance:
      - "SESSION 38: Framework v4.0 Compliance Enforcement"
      - "Root cause: Orquestador no leía principles.md ni consultaba precedentes"
      - "---"
      - "MEJORAS IMPLEMENTADAS:"
      - "1. Session-protocol v2.0 → v3.0:"
      - "   - Nueva FASE 0: CALIBRACIÓN v4.0"
      - "   - Paso 0.0: Leer principles.md al inicio"
      - "   - Paso 0.1: Revisar últimos 5 precedentes"
      - "   - Paso 0.2: Self-check v4.0 obligatorio"
      - "   - Fases renumeradas (Vigilancia → FASE 1, etc.)"
      - "   - Paso 5.1: Verificar cumplimiento v4.0 al cierre"
      - "2. Error-patterns.md:"
      - "   - Error #35: No seguir Framework v4.0 completo"
      - "3. Agent-protocol.md:"
      - "   - Nueva sección: INSTRUCCIONES v4.0 PARA AGENTES"
      - "   - Cuando invoco agentes de decisión, incluir contexto v4.0"
      - "4. CLAUDE.md:"
      - "   - session-protocol referencia actualizada a v3.0"
      - "5. Decisions_log.yaml:"
      - "   - Documentada decisión TEP.PA HOLD como precedente"
      - "---"
      - "IMPACTO ESPERADO:"
      - "   - Orquestador calibra con principios al inicio de sesión"
      - "   - Precedentes consultados antes de decisiones"
      - "   - Agentes reciben contexto v4.0 en sus prompts"
      - "   - Self-check al cierre verifica cumplimiento"
    applied:
      - "2026-02-01: Fusion self-evolution+evolution-manager - system-evolver"
      - "2026-02-01: health-check upgraded haiku-sonnet, +quantitative checks"
      - "2026-02-01: TTE moved active-watchlist"
      - "2026-02-01: system.yaml compacted 863-~350 lines"
    applied_2026_02_05_proactive_vigilance:
      - "MAJOR SYSTEM UPGRADE: Proactive Vigilance Framework"
      - "Root cause: Recomendamos NVO sin contextualizar el timing (caída 18% previa)"
      - "---"
      - "NUEVOS AGENTES (3):"
      - "  - news-monitor: Escanea noticias 48h de todas las posiciones al inicio de sesión"
      - "  - market-pulse: Detecta movimientos anómalos de precio y busca causa"
      - "  - risk-sentinel: Vigila litigios, regulación, investigaciones (semanal)"
      - "---"
      - "NUEVOS SKILLS (3):"
      - "  - news-classification: Framework para clasificar noticias por impacto"
      - "  - error-detector: Checklist OBLIGATORIO antes de cada recomendación"
      - "  - recommendation-context: Template para contextualizar cada recomendación"
      - "---"
      - "NUEVAS RULES (2):"
      - "  - session-protocol v2.0: Añade Fase 0 Vigilancia obligatoria"
      - "  - meta-reflection-integration: Protocolo para integrar reflexiones de agentes"
      - "---"
      - "NUEVOS STATE FILES (3):"
      - "  - state/news_digest.yaml: Output de news-monitor"
      - "  - state/market_pulse.yaml: Output de market-pulse"
      - "  - state/risk_alerts.yaml: Output de risk-sentinel"
      - "---"
      - "ACTUALIZACIONES:"
      - "  - agent-registry: Añadido dominio VIGILANCIA con 3 agentes"
      - "  - CLAUDE.md: Añadida sección vigilancia y referencias a nuevos skills"
      - "  - error-patterns.md: Añadidos errores #31-34 (contexto, noticias, movimientos, meta-reflection)"
      - "---"
      - "IMPACTO ESPERADO:"
      - "  - No más sorpresas de noticias en posiciones activas"
      - "  - Recomendaciones siempre contextualizadas con timing"
      - "  - Errores documentados se detectan ANTES de actuar"
      - "  - Reflexiones de agentes se integran sistemáticamente"
    applied_2026_02_04_health_check:
      - "Health check ejecutado: score 9.1/10"
      - "WARNING: Falta energy.md sector view"
      - "WARNING: CLAUDE.md >150 lineas (752)"
      - "INFO: LIGHT.NV/AS ticker inconsistencia"
      - "19 agentes OK, 18 skills OK, 7 tools OK"
      - "18 posiciones = 18 thesis OK"
      - "Sector views: 10/11 sectores cubiertos"
    applied_2026_02_03_utg_review:
      - "UTG.L re-evaluated with v2.0 framework: VALIDATED"
      - "Standing order at 540 GBp MAINTAINED"
      - "FV updated: 745 GBp (was 770 GBp) - weighted expected value more conservative"
      - "MoS at 540p = 27.5% (passes 25% Tier B threshold)"
      - "Value trap checklist: 1.5/10 (PASS)"
      - "Narrow moat via Efficient Scale (near-monopoly UK listed PBSA)"
      - "Multi-method valuation: NAV (40%), DDM (30%), FFO Multiple (30%)"
      - "Bear/Base/Bull scenarios: 610p/745p/870p"
      - "Key risk: Immigration policy reducing international student demand"
      - "Earnings Feb 24: watch occupancy guidance FY2027/28"
      - "Thesis v2.0 created: thesis/research/UTG.L/thesis_v2.md"
    applied_2026_02_03_hpq_review:
      - "HPQ re-evaluated with v2.0 framework: REJECTED as value trap"
      - "4/10 value trap factors: secular decline, digital disruption, negative equity, insider selling"
      - "MoS 22% vs 35% required for Tier C quality score 5/10"
      - "Standing order at $18.50 ELIMINATED"
      - "Thesis moved to thesis/archive/HPQ/thesis.md"
    applied_2026_02_03_session25:
      - "Re-evaluacion PFE: FV $27.52 (era $32-35), MoS 3-10% (era 25-36%) - FAIRLY VALUED"
      - "Re-evaluacion ALL: FV $240 (confirmado), MoS 16% (era 21%) - MODERATELY UNDERVALUED"
      - "Re-evaluacion SHEL.L: FV L26.8 (era L32-35), MoS -4% (era 25-30%) - FAIRLY VALUED"
      - "Re-evaluacion GL: FV $174 (era $215), MoS 17.6% (era 34%) - HOLD (was BUY). P/B vs ROE method."
      - "Framework v2.0 es ~20pp mas conservador que analisis original"
    applied_2026_02_02:
      - "Fixed SHEL-SHEL.L ticker bug (+$427 phantom value)"
      - "Fixed dcf_calculator.py GBp/GBP mismatch for LSE stocks"
      - "Portfolio fully synced with eToro (13 positions)"

# -----------------------------------------------------------------------------
# PIPELINE TRACKER - Rutinas operativas del fondo
# Ver .claude/skills/pipelines/SKILL.md para definicion completa
# -----------------------------------------------------------------------------
pipeline_tracker:
  # DIARIOS
  vigilance:
    frequency: daily
    last_run: 2026-02-11
    next_due: 2026-02-12
    last_result: "TMUS earnings today (post-close). DTE.DE framework ready. ZIG.L 3.1% from trigger. No critical news."
  rotation_check:
    frequency: daily
    last_run: 2026-02-11
    next_due: 2026-02-12
    last_result: "13 positions. Cash 44%. TMUS impact on DTE.DE pending tonight. Earnings dense week Feb 23-26."
  # SEMANALES
  opportunity_scan:
    frequency: weekly
    last_run: 2026-02-11
    next_due: 2026-02-18
    last_result: "V2 full universe scan. 2,052 tickers screened. 5 Tier A: PAYC(85), FSG.L(83), NFLX(75), PAYX(75), RMV.L(69adj). DSY.PA buy-pipeline COMPLETED (APPROVED EUR 15.50). PAYC R1 done, awaiting earnings. MORN framework ready. Pipeline HEALTHY."
  risk_review:
    frequency: weekly
    last_run: 2026-02-09
    next_due: 2026-02-16
    last_result: "Risk-sentinel first run: 0 RED, 5 ORANGE. 12 gaps found. Top: SAN.PA CTCL lawsuits, IMB.L $400M payment. Positive: GL SEC cleared, HRB Direct File dead."
  # QUINCENALES
  position_review:
    frequency: biweekly
    last_run: 2026-02-08
    next_due: 2026-02-22
    last_result: "Adversarial Fase 2: 9 Tier C reviewed. 3 SELL, 6 HOLD. All with conviction+exit_plan."
    current_batch: "middle"
    batch_rotation: ["bottom", "middle", "top"]
  system_health:
    frequency: biweekly
    last_run: 2026-02-04
    next_due: 2026-02-18
    last_result: "9.1/10. Warnings: energy.md missing, CLAUDE.md >150 lines"
  # MENSUALES
  deep_performance:
    frequency: monthly
    last_run: 2026-02-11
    next_due: 2026-03-11
    last_result: "13 positions reviewed. P&L +$70.53 (+1.2%). Cash 48.5%. 2 OVERVALUED vs FV (VICI -1.3%, UHS -2.1%). 5 earnings Feb 23-26. 3 adversarial reviews pending. Tier C = 43% invested (inverse of Tier A strategy). Report: thesis/research/deep_performance_2026_02_11.md"
  macro_refresh:
    frequency: monthly
    last_run: 2026-02-02
    next_due: 2026-03-02
    last_result: "Tariffs escalando, Iran tension up, China mejora"
  system_challenge:
    frequency: monthly
    last_run: 2026-02-11
    next_due: 2026-03-11
    last_result: "First run: 5 challenges (1 CRITICAL, 3 HIGH, 1 MODERATE). Actions: mentalidad competitiva removed, QS market_position default 0, UK concentration documented, 2 standing orders cancelled (EVO.ST, BBWI), adversarial FV tracking created, 3-month feasibility review scheduled."

# -----------------------------------------------------------------------------
# ADVERSARIAL REVIEW PROJECT - Iniciado Sesión 48 (2026-02-07)
# Re-evaluar todo el portfolio + standing orders con pipeline adversarial
# Al completar: position-review pipeline ya será adversarial por defecto
# -----------------------------------------------------------------------------
adversarial_review:
  status: COMPLETED
  started: 2026-02-07
  completed: 2026-02-11
  objective: "Re-evaluar todas las posiciones y standing orders con pipeline adversarial."
  results: |
    Fases 1-4 COMPLETED (all Tier C, B, standing orders reviewed).
    8 positions SOLD: A2A.MI, VNA.DE, TATE.L, SAN.PA, HRB, IMB.L (adversarial), SHEL.L, TEP.PA, LIGHT.AS, PFE, FUTR.L (pre-adversarial rotations).
    3 standing orders CANCELLED: BME.L, UTG.L, WKL.AS.
    12/13 positions had inflated FV (avg -15%). Pattern: every thesis overrated QS.
    Fase 5 (LULU, AUTO.L, BYIT.L): deferred to regular position-review pipeline — Tier A, lowest risk of FV inflation.
  lesson_learned: "DNLM.L thesis tenía FV 24% inflado. NIC £18M omitido, insider selling omitido, CEO change omitido. Pipeline adversarial lo detectó."

  # REVIEW PIPELINE POR POSICION (más ligero que buy-pipeline completo):
  # Ronda 1: risk-identifier + valuation-specialist (PARALELO)
  # Ronda 2: review-agent con veredicto HOLD/ADD/TRIM/SELL
  # Ronda 3: devil's-advocate SOLO si discrepancia material vs thesis
  # Ronda 4: investment-committee SOLO si SELL/TRIM recomendado

  # PRIORIDAD: earnings_urgentes > tier_c > standing_orders > tier_b > tier_a

  # ===== FASE 1: EARNINGS URGENTES (antes del 23 Feb) =====
  fase_1_earnings:
    status: COMPLETED
    target_sessions: "49-50"
    positions:
      - { ticker: MONY.L, tier: A, earnings: "2026-02-23", reviewed: true, date: "2026-02-07", verdict: "HOLD LOW conviction", fv_revision: "277→201 GBp (-27%)", notes: "ROIC 29%>>WACC, CEO buying, earnings decisive" }
      - { ticker: EDEN.PA, tier: B, earnings: "2026-02-24", reviewed: true, date: "2026-02-07", verdict: "HOLD MEDIUM conviction", fv_revision: "38.4→29.0 EUR (-24.5%)", notes: "Italy 120M not in FV, Brazil 19% not 9.5%, ROIC>>WACC" }
      - { ticker: DTE.DE, tier: C, earnings: "2026-02-26", reviewed: true, date: "2026-02-07", verdict: "HOLD MEDIUM conviction", fv_revision: "36.50-38.50→33-35 EUR (-9%)", notes: "Thesis claims Tier A but QS=48 Tier C. ROIC spread -0.7pp. Leverage 3.3x not 2.6x. Revenue CAGR 1.8% not 4%." }
      - { ticker: UHS, tier: C, earnings: "2026-02-25", reviewed: true, date: "2026-02-10", verdict: "HOLD LOW conviction ON PROBATION", fv_revision: "283.74→213 USD (-24.9%)", notes: "Thesis v3.0 written 2026-02-10. OBBBA Medicaid $1T cuts = structural risk. DOJ $122M + OIG 5yr. Behavioral volumes soft. FV $213 = MoS ~0%. Pre-earnings framework ready. Post-earnings SELL/HOLD MANDATORY." }

  # ===== FASE 2: TIER C - Mayor riesgo de FV inflado (9 posiciones) =====
  fase_2_tier_c:
    status: COMPLETED
    completed_date: 2026-02-08
    target_sessions: "51"
    positions:
      - { ticker: A2A.MI, score: 37, reviewed: true, date: "2026-02-08", verdict: "SELL", fv_revision: "2.70→2.04 EUR (-24%)", notes: "ROIC -3.0pp, EBIT overstated 25%, QS 37 Tier C (thesis claimed A). SOLD." }
      - { ticker: VNA.DE, score: 41, reviewed: true, date: "2026-02-08", verdict: "SELL", fv_revision: "32.58→24.35 EUR (-25%)", notes: "ROIC -6.6pp, refinancing wall EUR 10.2B, QS 41 Tier C (thesis claimed B). SOLD." }
      - { ticker: TATE.L, score: 45, reviewed: true, date: "2026-02-08", verdict: "SELL", fv_revision: "551→329-430 GBp (-22 to -40%)", notes: "QS 45 Tier C. ROIC -0.5pp. D&A error (100M vs 172M actual). Consistent with TEP.PA/PFE/LIGHT.AS sell precedent. SOLD 2026-02-08. P&L +3.5%." }
      - { ticker: DTE.DE, score: 48, reviewed: true, date: "2026-02-10", verdict: "HOLD MEDIUM", fv_revision: "37.50→34.00 EUR (-9.3%)", notes: "Thesis v3.0 written. QS 48 Tier C (no adj). FV EUR 34 (EV/EBITDA 6.5x + P/E 14x 2026E + SOTP). MoS 10.5%. Net neutrality YELLOW (low risk). TMUS Capital Markets Day today. Pre-earnings framework for Feb 26." }
      - { ticker: UHS, score: 51, reviewed: true, date: "2026-02-10", verdict: "HOLD LOW ON PROBATION", fv_revision: "283.74→213 USD (-24.9%)", notes: "Thesis v3.0 written. QS 51 Tier C (no adj). FV $213 (EV/EBITDA 7.0x + P/E 10x FY26E, -7% Medicaid haircut). MoS ~0%. OBBBA Medicaid cuts NOW LAW ($1T, $360-400M UHS impact by 2032). DOJ $122M + 5yr OIG. Behavioral volumes soft (Q1 decline, Q2-Q3 <1%). Post-earnings Feb 25 SELL/HOLD MANDATORY." }
      - { ticker: GL, score: 52, reviewed: true, date: "2026-02-08", verdict: "HOLD MEDIUM-LOW", fv_revision: "174→185 USD (+6%)", notes: "Anomaly: thesis was too conservative. ROE 16-21%>>Ke 6.6-8.1%. 4 class actions found (thesis had 1). QS tool miscalibrated for insurers." }
      - { ticker: IMB.L, score: 54, reviewed: true, date: "2026-02-10", verdict: "SELL EXECUTED", fv_revision: "3701→2796 GBp (-24.4%)", notes: "SOLD 2026-02-10 @ 3,278p. P&L +6.9%. Thesis v3.0 FV 2,796p. MoS -14.6% (overvalued). $400M HMRC + UK generational ban + dividend cut history. Worst QS misgrade in portfolio (54 vs claimed 95)." }
      - { ticker: ALL, score: 56, reviewed: true, date: "2026-02-08", verdict: "HOLD PROBATION LOW", fv_revision: "240→234 USD (-2.5%)", notes: "QS 56 Tier B (thesis claimed Tier A). ROE 37% is peak cycle (normalized 15-18%). Arity data privacy litigation absent from thesis. Risk-adj FV $214. MoS 11.3% thin for Tier B." }
      - { ticker: VICI, score: 54, reviewed: true, date: "2026-02-10", verdict: "HOLD PROBATION LOW", fv_revision: "33.75→29.00 USD (-14.1%)", notes: "Thesis v3.0 written. QS Tool 54, REIT-Adj ~60 Tier B. FV $29.00 (DDM $28.66 + NAV $26.06 + P/AFFO $29.63). Caesars Regional 1.03x (25% NOI), LV tourism -7-9% YoY, 3 analyst downgrades (Evercore/WFC/Scotia). KC#7 added: rent cut >10% w/o compensation. HOLD through Feb 25 earnings." }

  # ===== FASE 3: STANDING ORDERS (full adversarial) =====
  fase_3_standing_orders:
    status: COMPLETED
    completed_date: 2026-02-11
    target_sessions: "52-53"
    orders:
      - { ticker: BME.L, trigger: "169 GBp", reviewed: true, date: "2026-02-09", verdict: "CANCELLED", note: "Governance broken + ROIC collapsed. Adversarial review disqualified. Standing order cancelled per user instruction." }
      - { ticker: UTG.L, trigger: "540 GBp", reviewed: true, date: "2026-02-09", verdict: "CANCELLED", note: "QS Tier D + FV -17.4% in adversarial. Quality insufficient. Standing order cancelled per user instruction." }
      - { ticker: TATE.L, trigger: "350 GBp ADD", reviewed: true, date: "2026-02-08", verdict: "N/A", note: "Position closed 2026-02-08 (adversarial sell)" }
      - { ticker: WKL.AS, trigger: "65 EUR", reviewed: true, date: "2026-02-11", verdict: "WATCHLIST at EUR 50-55 post-earnings", note: "Full adversarial buy-pipeline (4 rounds). FV 94.28→72 EUR (-24%). Standing order CANCELLED. 3 gates failed. STRONG COUNTER 10/19. See committee_decision.md." }

  # ===== FASE 4: TIER B (4 posiciones) =====
  fase_4_tier_b:
    status: COMPLETED
    completed_date: 2026-02-10
    target_sessions: "52-53"
    positions:
      - { ticker: HRB, score: 70, reviewed: true, date: "2026-02-09", verdict: "SELL EXECUTED", fv_revision: "59.58→33.94 USD (-43%)", notes: "SOLD 2026-02-09 @ $32.77. P&L -13.25%. Intuit moat breach. Counter 18/24 STRONG. IRS Direct File death does NOT change verdict." }
      - { ticker: EDEN.PA, score: 62, reviewed: true, note: "Reviewed in fase_1. FV 38.4→29.0 EUR. HOLD MEDIUM." }
      - { ticker: DOM.L, score: 61, reviewed: true, date: "2026-02-10", verdict: "HOLD LOW", fv_revision: "294→240 GBp (-18.4%)", notes: "FCF conversion 85→43-52% (KEY ERROR). Store growth 50→25-35/yr. Margins compressed 21→19-20%. CEO resolved (Dominic Paul). MoS 19.2% marginal for Tier B. FY25 results Mar 5 = decision point." }
      - { ticker: SAN.PA, score: 59, reviewed: true, date: "2026-02-09", verdict: "SELL EXECUTED", fv_revision: "122.02→78.69 EUR (-35.5%)", notes: "SOLD 2026-02-09 @ EUR 80.29. P&L -0.84%. Amlitelimab inferior to Dupixent. ROIC<WACC (-2.1pp). 8th ROIC<WACC exit." }

  # ===== FASE 5: TIER A (6 posiciones - quick check) =====
  # ALL 6 NOW REVIEWED. LULU, AUTO.L, BYIT.L completed 2026-02-11.
  fase_5_tier_a:
    status: COMPLETED
    completed_date: 2026-02-11
    target_sessions: "53-55"
    all_reviewed: true
    positions:
      - { ticker: ADBE, score: 76, reviewed: true, date: "2026-02-10", verdict: "HOLD MEDIUM", fv_revision: "394→390 USD (-1%)", notes: "FTC/DOJ ROSCA lawsuit integrated. QS Tool 76→Adj 73. KC#6 added. Trial Oct 19 2026." }
      - { ticker: NVO, score: 73, reviewed: true, note: "QS Tool-First: 73 Tier B (was 82 Tier A). Adversarial FV 68-70. Reviewed session 51." }
      - { ticker: MONY.L, score: 81, reviewed: true, note: "Reviewed in fase_1. FV 277→201 GBp. HOLD LOW." }
      - { ticker: LULU, score: 82, reviewed: true, date: "2026-02-11", verdict: "HOLD LOW-MED", fv_revision: "261→202 USD (-22.6%)", notes: "QS Tool 80-81 (Tier A maintained). Moat NARROW 14/25. Tariffs $320M, governance chaos. ADD conditional on Q4 + CEO." }
      - { ticker: AUTO.L, score: 79, reviewed: true, date: "2026-02-11", verdict: "HOLD MEDIUM", fv_revision: "688→617p (-10.3%)", notes: "QS Tool 63→Adj 71 (Tier A→B). Financial Quality 40/40 perfect. DMCC Act risk. ADD 450p CANCELLED." }
      - { ticker: BYIT.L, score: 68, reviewed: true, date: "2026-02-11", verdict: "HOLD PROBATION LOW", fv_revision: "455→345 GBp (-24.2%)", notes: "QS Tool 68→Adj 69-72 (Tier A→B). Insider 0.4% not 9.6%. Microsoft EA structural. Moat NARROW 14/25. ADD 260→240p." }
